Placebo-controlled Proof of Concept Study of Epelsiban in Women With Adenomyosis
Clinical trial NCT02794467 · WITHDRAWN
Trial details
- NCT number
- NCT02794467
- Sponsor
- GlaxoSmithKline
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-01
- Primary completion
- 2016-10-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.